Board of Directors resolved to convene the 2022 Annual Shareholders' Meeting
· Issued by Maxigen Biotech Inc.
Close
Today's Information
Provided by: MAXIGEN BIOTECH INC.
SEQ_NO
4
Date of announcement
2022/03/21
Time of announcement
20:56:32
Subject
Board of Directors resolved to convene
the 2022 Annual Shareholders' Meeting
Date of events
2022/03/21
To which item it meets
paragraph 17
Statement
1.Date of the board of directors' resolution:2022/03/21
2.Shareholders meeting date:2022/06/21
3.Shareholders meeting location: No. 88, Keji 1st Rd., Guishan District,
Taoyuan City (3rd Floor Meeting Room of the Company)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting): physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)The Company's 2021 Business Report.
(2)Audit Committee's review of the 2021 annual final
accounting books and statements.
(3)Report on 2021 employees and Directors' remuneration.
(4)2021 Annual Report on remuneration of Individual Directors.
6.Cause for convening the meeting (2)Acknowledged matters:
(1)2021 Business Report and Financial Statements.
(2)Proposal of 2021 earnings distribution
7.Cause for convening the meeting (3)Matters for Discussion:
(1)Issue new shares through the capitalization of retained earnings.
(2)Amendments to the Articles of Incorporation.
(3)Amendments to the Regulations Governing the Acquisition and Disposal
of Assets.
8.Cause for convening the meeting (4)Election matters:
By-election directors
9.Cause for convening the meeting (5)Other Proposals:
Approve the lifting of non competition restrictions for directors and
representatives.
10.Cause for convening the meeting (6)Extemporary Motions:None
11.Book closure starting date:2022/04/23
12.Book closure ending date:2022/06/21
13.Any other matters that need to be specified:
(1)Acceptance of shareholder proposal: from 15th April 2022 to 9am 25th
April 2022.The place where accepted the proposal: Maxigen Biotech Inc./
No. 88, Keji 1st Rd., Guishan District, Taoyuan City.
(2)The shareholders electronic voting from 22nd May 2022 to 18th June
2022.
